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The objective of the present study was to compare short and long term application of Echinacea 
purpurea root powder on growth performance and immunity response of broiler chicks. Three replicate 
trials involving a total of 600 day-old Ross chicks were used in this study. In each trial, a total of 200 
chicks were randomly allocated into 5 groups.  Each group consisted of 4 pens with 10 chicks in each 
pen. The birds in group A received control mash diet during the experiment, but those in groups B and 
C were given control diet supplemented with 0.1% (w/w) and 0.5% (w/w) E. purpurea root powder, 
respectively. The chicks in groups D and E received control diet supplemented with 0.1% (w/w) and 
0.5% (w/w) E. purpurea root powder, respectively, just for one week and fed control diet afterwards. The 
results showed that E. purpurea consumption for six weeks changed the total counts of white blood 
cells (WBCs), number of lymphocytes and heterophils, feed conversation ratio, and antibody titers 
against newcastle and avian influenza diseases (p < 0.05). In conclusion, this result suggests that 
feeding E. purpurea, particularly for long time, may improve feed conversion, change blood cells 
number and enhance immunity response in broilers.   
 





It has been suggested that herbal medicines can be good 
alternative for antibiotics as therapeutic and growth 
promoting agent. Therefore, herbal medicines have 
widespread use all over the world (Alexander and 
Chettle, 1977). One of the most important and popular 
medical herb is Echinacea purpurea (Barrett, 2003). This 
herbal medicine has been used from long time ago for a 
variety of purposes including treatment, growth enhance-
ment and immunostimulation (Percival, 2000; Barrett, 
2003).  
It has been reported that E. purpurea has an interferon 
(IFN) like effect, activating macrophages and inducing the 
production of interleukin (IL)-1 and IFN (Rininger et al., 
2000). E. purpurea has been shown to have non-specific 
immuno stimulatory properties in vitro (Bauer and 
Wagner, 1991), including increased phagocytosis 
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(Burger et al., 1997), and natural killer cell activity (See et 
al., 1997). However, due to: 1) the use of different plant 
parts (herb, roots, or both), 2) different methods of 
extraction, 3) the soil type in which the plant is grown and 
4) the phase of plant development at harvest; many 
products commonly summarized under the name E. 
purpurea can be chemically completely different 
preparations. Depending on these factors, Echinacea 
products can contain highly variable amounts of a variety 
of bioactive ingredients including caffeic acids, alkyl-
amides, polysaccharides and glycoproteins (Bauer and 
Wagner, 1991). However, results on the in vivo efficacy 
of Echinacea products have been controversial. While, 
Rehman et al. (1999) showed an increase in primary and 
secondary immunoglobin G response in rats treated with 
E. purpurea, animal and human studies have shown that 
E. purpurea had generally little or no effect on existing 
serum immunoglobin levels or on specific antibody 
production (Melchart et al., 1998; Grimm and Müller, 
1999; Turner et al., 2000).  
There are also some controversies on the consumption 





significant elevation in the number of lymphocytes in rat 
receiving E. purpurea extract for at least 8 weeks. 
Improvement in feed conversion was reported by Maass 
et al. (2005) in pig receiving E. purpurea cobs supple-
mentation for at least two weeks. Meanwhile, Currier and 
Miller (2000) showed that daily dietary administration of 
E. purpurea root extract to normal mice for one week 
resulted in a significant increase in the number of natural-
killer (NK) cells. Ma et al. (2009) in addition showed that 
administration of E. purpurea extract for one week 
significantly enhanced the infectious bursal disease 
antibody levels in the broiler’s blood.  
Therefore, our objectives were: a) using E. purpurea 
root powder instead of E. purpurea extract. b) deter-
mining the effects of dietary E. purpurea root powder on 
growth performance and immunity responses of broiler 
chicks, and c) comparing the effects of two different 
consumption periods of E. purpurea root powder. 
 
 
MATERIALS AND METHODS 
 
Two years old plants of E. purpurea were harvested in September 
2010 and the roots were cleaned, washed and sun-dried. The roots 
were ground and sifted, then mixed with basal diets. Determination 
of phenolic contents such as caftaric acid, chlorogenic acid, cichoric 
acid, and echinacoside in the dried, powdered E. purpurea root was 
performed by high-pressure liquid chromatography. The E. 
purpurea used in this study contained 1.54% cichoric acid, 0.4% 
caftaric acid, around 0.01% chlorogenic acid and about 0.01% 
echinacoside.  
Three replicate trials involving a total of 600 day-old Ross chicks 
were used in this study. In each trial, a total of 200 chicks were 
randomly allocated into 5 groups.  Each group consisted of 4 pens 
with 10 chicks in each pen. These chicks were floor reared. The 
birds in group A received control mash diet during the experiment, 
but those in groups B and C were given control diet supplemented 
with 0.1% (w/w) and 0.5% (w/w) E. purpurea root powder, 
respectively.  The chicks in groups D and E received control diet 
supplemented with 0.1% (w/w) and 0.5% (w/w) E. purpurea root 
powder, respectively, just for one week and fed control diet 
afterwards.  
The gross energy of Echinacea was estimated to be 3,240 
kcal/kg. Using the gross energy value of Echinacea and values 
from the NRC (1994), the diet was adjusted (NRC, 1994). So, soy 
oil was added with the Echinacea, and equal amounts of corn were 
removed. All chicks were fed for 6 weeks on broiler diet formulated 
(Table 1) to meet NRC requirements of broiler chicks (NRC, 1994). 
This diet along with water was available ad libitum throughout the 
experiment. According to laboratory recommendations, at 13 days 
of age, all birds were vaccinated with a bivalent oil emulsion of an 
inactivated vaccine containing both ND (Lenthogen) and AI (H9N2) 
viruses, subcutaneously.  
Ten chicks from each group were randomly weighted and bled 
via wing vein on days 21, 28, 35 and 42 of experiment. After 
weighing and collecting blood (aseptically) from chicks, they were 
marked with leg bands, to avoid reusing for blood collection. Blood 
samples (approximately 5 ml/sample) were collected in tubes either 
containing EDTA for hematological investigations or no 
anticoagulant agents for serological studies. White blood cell (WBC) 
counts and differentiation were assayed by Medonic-precision 
instrument for hematology research (CA620). Blood samples 
containing no anticoagulant agent were allowed to clot. They were 
then centrifuged at 4000 g for  10 min.  Sera  were  then  separated  




and stored at -20°C until the end of the experiment. The serum 
samples were tested for antibodies against newcastle disease virus 
(NDV) and avian influenza virus (AIV). The AIV and NDV specific 
antibodies levels were measured by Hemagglutination inhibition 
test according to Alexander and Chettle (1977) and Allan and 
Gough (1974), respectively.  
Feed intake and body weight were determined and their feed 
conversion ratio (FCR) was calculated. At the end of the 
experiment, all birds were slaughtered to determine the weight of 
carcass, bursa of fabricius, thymus and spleen. All samples were 
analysed and the results were assessed statistically using one way 
analysis of variances (ANOVA). Data were presented as mean ± 
SE and values differing at p < 0.05 were considered statistically 





As shown in Table 2, chicks in experimental groups 
showed better production performance than chicks in 
control group. There were no significant differences on 
feed intake and weight gain between control group (group 
A) and the experimental groups (p > 0.05). Birds 
receiving E. purpurea for 6 weeks had a greater weight 
gain and lower feed consumption in comparison to chicks 
receiving E. purpurea for one week. However, these 
differences were not significant (p > 0.05). E. purpurea 
consumption reduced feed conversion, but this reduction 
was only significant in groups B and C compared to 
group A (p < 0.05). Differences in the feed conversion 
between experimental groups were not significant (p > 
0.05). 
 As shown in Table 3, the total count of WBCs and 
number of lymphocytes in chicks receiving E. purpurea 
for 6 weeks was significantly higher than in the control 
group at days 21, 28, 35 and 42 (p < 0.05). Moreover, at 
age of 21 days, there was a significant increase in the 
number of lymphocytes in group D in comparison with 
group A (p < 0.05).  As presented in Table 3, at ages of 
21, 28 and 42 days, there were significant increase in 
number of heterophils in group C (receiving 0.5% E. 
purpurea for 6 weeks), compared to control group (p < 
0.05). Furthermore, at the age of 21 and 42 days, there 
was a significant increase in number of these cells in 
group B (receiving 0.1% E. purpurea for 6 weeks), when 
compared to control group (p < 0.05). There were no 
significant differences in the hematological parameters 
between B, C, D and E groups (p > 0.05).  
As shown in Table 4, antibody titers against NDV were 
increased in all supplementation groups in comparison to 
the control group. However, this elevation was only 
significant for experimental groups B and C (p < 0.05). No 
significant difference in antibody titers was detected 
among the different modes of treatments (p > 0.05). More 
also, according to Table 5, antibody titers against AIV 
were significantly affected by supplementation of E. 
purpurea for 6 weeks compared with group A (p < 0.05). 
There was no significant difference in the antibody titer 
among the experimental groups receiving E. purpurea (p 
> 0.05).   Although   percentage   of   bursa   of   fabricius,  




Table 1. Composition and calculated analysis of the experimental diets. 
 
Ingredient Starter (%)  (1 to 21 days) Finisher (%) (22 to 42 days) 
Corn 46.71 56.11 
Soybean meal (44%) 37.21 31.24 
Sunflower oil 7.7 6.21 
Fish meal (64%) 4.95 3 
Oyster 1.22 1.19 
Dicalcium phosphate 1.04 1.06 
Vitamin premix 0.3 0.3 
Mineral premix 0.3 0.3 
Salt (NaCl) 0.22 0.26 
Methionine 0.15 0.03 
Vitamin E 0.1 0.1 
Vitamin D3 0.1 0.1 
Vitamin K - 0.1 
Total  100 100 
   
Calculated analysis   
ME (kcal/kg) 3200 3200 
Crude protein 23 20 
C/P ratio 139 160 
Calcium 1 0.9 
Available phosphorus 0.45 0.4 
Sodium 0.15 0.15 
Methionine + cysteine 0.93 0.72 
Methionine 0.57 0.4 
Lysine 1.44 1.19 
Arginine 1.63 1.41 
 
 
thymus and spleen to live body weight were greater in 
experimental groups compared with control group (Table 





FCR and body weight gain are sensitive indicators of 
non-specific body response against any substances used 
in live animals. Based on the results presented in Table 
2, broilers in the experimental groups B and C receiving 
E. purpurea for 6 weeks showed an improvement in 
mean feed conversion ratio compared to the control 
group (p < 0.05), although there was no significant 
change in condition factor between these experimental 
groups and control group. The mode of action of the herb 
mixtures on feed conversion is through the enhancement 
of the digestive functions (Przybilla and Weiss, 1998). 
The improvement of feed conversion ratio with feeding E. 
purpurea is in agreement with the findings of Maass et al. 
(2005) who also reported that E. purpurea 
botanicals(herbs and/or spices), supplementation as feed 
additive improved feed conversion. Meanwhile, there are 
some controversies on the effect of E. purpurea extract 
on feed conversion. While, Ma et al. (2009) reported that 
E. purpurea extract significantly lowered the feed con-
version efficiency in broilers, Roth-Maier et al. (2005) 
claimed that E. purpurea extract as a feed additive for 
broilers and layers is not beneficial for growth or layer 
performance. It has also been shown that E. purpurea 
increases the non-specific activity of the immune system. 
This includes increased phagocytosis (Stotzem et al., 
1992), increased cytokine production (Burger et al., 
1997), and natural killer cell activity (See et al., 1997). In 
this study, the significantly increased total count of WBCs 
was associated with the increase in lymphocytes and 
heterophils (Table 3). This may explain the efficacy of E. 
purpurea in terms of the health status and non-specific 
immune response. The significant increase in 
lymphocytes might also indicate the specific and non- 
specific immune stimulant role of E. purpurea. Bauer 
(1996) found in vitro and in vivo  pharmacological  effects  




Table 2. Effect of E. purpurea on production performance of broiler chicks (M ± SE).  
 
Parameter  Group A  (control) Group B (6 weeks 0.1%) Group C (6 weeks 0.5%) Group D (1 week 0.1%) Group E (1 week 0.5%) 
Initial body wt. (g) 47.04 ± 1.1 46.52 ± 2.5 47.87 ± 2.6 45.63 ± 3.3 46.58 ± 2.3 
Final body wt. (g) 1579.6 ± 70 1618.8 ± 72 1622.7 ± 47 1597.9 ± 99 1605.3 ± 51 
Total gain (g) 1532.56 ± 64 1572.28 ± 39 1574.83 ± 55 1552.27 ± 76 1558.72 ± 45 
Feed consumption (g) 3484.47 3441.91 3416.89 3476.32 3470.76 
Feed Conversion (g/g) 2.20 2.12* 2.10* 2.17 2.16 
 




Table 3. Effect of E. purpurea on some hematological parameters of chicks (M ± SE). 
 
Day Parameter (ml) Group A (control) Group B (6 weeks 0.1%) Group C (6 weeks 0.5%) Group D (1 week 0.1%) Group E (1 week 0.5%) 
21 
WBC (×103) 24.16 ± 1.3 30.65 ± 1.3* 30.86 ± 1.1* 27.34 ± 1.6 28.26 ± 1.7 
Heterophil 809.36 ± 12 1034.43 ± 19* 1043.68 ± 11* 918.62 ± 16 955.18 ± 15 
Lymphocyte 1401.28 ± 23 1800.68 ± 24* 1817.65 ± 25* 1604.85 ± 32 1656.03 ± 26* 
Monocyte 193.28 ± 8 216.08 ± 2 211.69 ± 3 198.21 ± 5 203.47 ± 7 
Eosinophil 12.08 ± 0.6 13.79 ± 0.9 12.96 ± 0.7 12.3 ± 0.2 11.30 ± 0.3 
       
28 
WBC (×103) 24.74 ± 1.8 30.18 ± 1.6* 31.11 ± 1.3* 27.74 ± 1.6 27.77 ± 1.5 
Heterophil 816.42 ± 12 1001.97 ± 29 1039.96 ± 34* 920.96 ± 19 920.57 ± 13 
Lymphocyte 1459.66 ± 56 1793.69  ± 16* 1854.15  ± 86* 1647.75  ± 80 1646.76  ± 69 
Monocyte 183.07 ± 8 208.24 ± 6 203.31 ± 4 191.40 ± 2 195.77 ± 9 
Eosinophil 14.84 ± 0.4 15.09 ± 0.8 13.99 ± 0.4 13.87 ± 0.15 13.88 ± 0.9 
       
35 
WBC (×103) 25.39 ± 1.2 30.81 ± 1.8* 31.18 ± 1.9* 28.56 ± 1.2 29.15 ± 1.3 
Heterophil 842.94 ± 24 1033.67  ± 20 1048.27  ± 12 953.90  ± 74 976.52 ± 36 
Lymphocyte 1485.31 ± 78 1823.95 ± 34* 1855.20 ± 85* 1685.04  ± 60 1719.85  ± 15 
Monocyte 198.04 ± 3 209.50 ± 7 200.48 ± 4 203.63 ± 3 205.50 ± 4 
Eosinophil 12.69 ± 0.5 13.86 ± 0.3 14.03 ± 0.6 13.42 ± 0.7 13.11 ± 0.7 
       
42 
WBC (×103) 25.23 ± 1.5 30.51 ± 1.1* 30.72 ± 1.5* 27.26 ± 1.1 28.12 ± 1.3 
Heterophil 837.63 ± 21 1023.91  ± 10* 1032.19 ± 28* 911.84  ± 37 942.02 ± 16 
Lymphocyte 1470.90 ± 53 1793.98  ± 76* 1812.48  ± 49* 1597.43 ± 79 1647.83 ± 85 
Monocyte 201.84 ± 7 218.45 ± 6 213.19 ± 9 203.08 ± 3 208.08 ± 5 
Eosinophil 12.61 ± 0.5 14.64 ± 0.6 14.13 ± 0.6 13.63 ± 0.9 14.06 ± 0.3 
 
* = p < 0.05 vs. Group A. 




Table 4. Effect of E. purpurea on antibody titer (log2 HI titer) against Newcastle virus at different ages (M ± SE). 
    
Day Group A  (control) Group B (6 weeks 0.1%) Group C (6 weeks 0.5%) Group D (1 week 0.1%) Group E (1 week 0.5%) 
21 2.08 ± 0.48 2.17 ± 1.26* 2.15 ± 0.67* 2.11 ± 0.48 2. 15 ± 0.53 
28 1.96 ± 0.23 2.21 ± 0.41 * 2.37 ± 0.43* 2.11 ± 0.64 2.08 ± 0.25 
35 2.16 ± 0.46 2.30 ± 0.34* 2.55 ± 0.37* 2.28 ± 0.80 2.08 ± 0.99 
42 2.11 ± 0.55 2.19 ± 0.81* 2.48 ± 0.58* 2.14 ± 0.43 2.13 ± 0.54 
 




associated with extracts from the aerial parts of E. 
purpurea and the alcoholic extracts of the roots of 
E. purpurea, E. angustifolia and E. pallida. The 
effects were mainly linked to a modulation of the 
non-specific cellular immune system by 
polysaccharides, glycoproteins, caffeic acid 
derivatives and alkylamides. Moreover, the 
various immune cells (macrophages, monocytes 
and natural killer cells) were stimulated in vitro by 
Echinacea extract (Bauer, 1998, 1999; Sun et al., 
1999; Rininger et al., 2000). 
The results of this study generally indicate that 
E. purpurea increased total counts of WBCs and 
the number of heterophils and lymphocytes. This 
is in agreement with Cundell et al. (2003) who 
found a significant increase of lymphocytes in rats 
fed with dried Echinacea preparations. It has been 
reported that ethanolic juice of Echinacea 
increased the number of lymphocytes and total 
leucocytes significantly (p < 0.05) in hens and pigs 
(Bohmer et al., 2009). Jurkstine et al. (2004) 
reported that E. purpurea extract from root were 
more effective phytoimmunostimulators than 
those from above-ground parts. E. purpurea 
extract from root significantly increased in vivo the 
number of leucocytes and lymphocytes. It is 
reported that Echinacea activates rat immune 
system. It could increase the number of lympho-
cytes too. However, elevation in the number of 
lymphocytes can be statistically reliable only if rats 
are fed Echinacea for at least eight weeks 
(Skaudickas et al., 2003). ND and AI HI-antibody 
titers were routinely examined to evaluate the 
effect of E. purpurea on humoral immune 
response of the chickens. Some statis-tical 
differences between the experimental and control 
groups were observed at different days of age; 
however, mean HI- antibody titers in all groups 
were above the protective level and the titers were 
considered uniform, which means that the 
chickens in all groups were properly immunized 
by vaccine (Tables 4 and 5).  The results of the 
present study revealed that the E. purpurea 
consumption neither for 1 nor 6 weeks had effect 
on lymphoid organs weight (Table 6), but 
increased antibody titers against NDV and AIV 
(Tables 4 and 5). Scientific studies indicate that 
Echinacea derived polysaccharides; alkylamides 
and cichoric acid each possess health-promoting 
properties. Since the Echinacea used in this study 
is a complex mixture, any or several of the 
components could be responsible for the effects 
seen. Although the exact mode of action of 
Echinacea is still not clearly understood, it is 
possible that its stimulatory activities allow it to 
exhibit properties comparable to those of an 
immunological adjuvant. In accordance to present 
study, Rehman et al., (1999) reported that 
Echinacea administration for six weeks increased 
IgG pro-duction in the early to middle term in rats. 
A rapid and strong elevation in the NDV antibody 
titer in the layers treated with Echinacea was 
reported by Bohmer et al. (2009). Elevated 
antibody titer against NDV was reported in broiler 
chicks with supplement of (1 g.L-1 drinking water) 
E. purpurea as well (Zhang, 2005). This investi-
gator reported also that E. purpurea extract (1 g.L-
1
 drinking water) used for five days, significantly 
augmented the infectious bursal disease antibody 
production in chickens (Zhang, 2005). Ma et al. 
(2009) reported that antibody titer against 
infectious bursal disease was improved in broiler 
chicks fed 0.1 to 1 g E. purpurea. 
The results of the present study demonstrate 
that feed supplementation with E. purpurea results 
in non-significantly lower feed consumption and 
higher weight gain, which indicate the beneficial 
effects of this herb on feed intake and weight gain. 
Based on the results of the current study, feeding 
E. purpurea for 6 weeks, particularly at concen-
tration of 0.5%, had the most positive effects on 
performance parameters. Whereas, increasing the 
E. purpurea supplementation length had 
significant effects on total count of WBC and 
number of lymphocytes and heterophils. The 
study revealed that E. purpurea supplementation 
particularly for 6 weeks also enhanced the specific 




Table 5. Effect of E. purpurea on antibody titer (log2 HI titer) against Avian Influenza virus at different ages (M ± SE).  
  
Day Group A  (control) Group B (6 weeks 0.1%) 
Group C (6 weeks 
0.5%) 
Group D (1 week 
0.1%) 
Group E (1 week 
0.5%) 
21 2.75 ± 0.81 3.37 ± 0.32* 3.73 ± 0.50* 3.25 ± 0.49 3.33 ± 0.88 
28 2.83 ± 0.52 3.5 ± 6.82* 3.91 ± 0.42* 3.14 ± 0.76 3.06 ± 0.73 
35 3.00 ± 0.73 3.41 ± 0.37* 3.55 ± 0.74* 3.23 ± 0.98 3.03 ± 0.9 
42 3.00 ± 1.08 3.33 ± 1.01* 3.62 ± 0.71* 3.18 ± 0.92 3.12 ± 1.5 
 




Table 6. Effect of E. purpurea on lymphoid organs (expressed by percentage of live weight) of broiler chicks at 42 days of age (M ± SE). 
 
Organ  Group A  (control) Group B (6 weeks 0.1%) 
Group C (6 weeks 
0.5%) 
Group D (1 week 
0.1%) 
Group E (1 week 
0.5%) 
Bursa of 
Fabricius  0.085 ± 0.016 0.094 ± 0.018 0.098 ± 0.011 0.090 ± 0.014 0.092 ± 0.012 
Thymus  0.370 ± 0.063 0.401 ± 0.055 0.471 ± 0.032 0.371 ± 0.037 0.397 ± 0.032 









E. purpurea root powder supplementation could therefore 
be used in broilers diet to improve performance and to 
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